Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2025 02:30 ET | Source: Curium

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a registrational Phase 2 clinical trial has been initiated in Japan...
October 08, 2025 06:22 ET | Source: Curium

Oxford Set To Benefit From New Technology to Diagnose Disease

Curium will shortly open a new facility to manufacture cutting-edge diagnosis technology for diseases like cancer at the Churchill Hospital site, part of Oxford University Hospitals NHS Foundation...
October 08, 2025 06:22 ET | Source: Curium

Newcastle Set To Benefit From New Technology to Diagnose Disease

Newcastle University has entered into a lease agreement with Curium for a new site dedicated to the manufacture of cutting-edge diagnostic technologies for diseases such as cancer. The facility will...
May 21, 2025 05:42 ET | Source: Curium

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which...
May 12, 2025 07:05 ET | Source: Curium

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has exclusive distribution rights for PYLCLARI® across Switzerland ZURICH,...
April 10, 2025 05:00 ET | Source: Curium

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

The acquisition of Nucleis will: Enhance Curium’s PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western EuropeImprove reliability and accessibility...
April 02, 2025 00:01 ET | Source: Curium

Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.

ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m...
March 28, 2025 19:40 ET | Source: Curium US LLC

Curium Finaliza a Aquisição da Monrol como Parte do seu Plano para Expandir Significativamente a Capacidade de Lutécio-177 e Pegada PET

Aquisição posiciona a Curium como principal fabricante do isótopo Lu-177Oferece experiência inovadora em P&D e pipeline para a CuriumAprimora a cobertura geográfica e a cadeia de suprimentos SPECT...
March 28, 2025 19:40 ET | Source: Curium US LLC

Curium Menyelesaikan Akuisisi Monrol sebagai Bagian dari Rencananya untuk Secara Signifikan Meningkatkan Kapasitas Lutetium-177 dan Jaringan PET

Menempatkan Curium sebagai produsen terkemuka isotop Lu-177Memberikan keahlian Litbang dan rangkaian tahap pengembangan produk (pipeline) yang inovatif ke CuriumMeningkatkan jangkauan geografis dan...
March 28, 2025 19:40 ET | Source: Curium

Curium schließt Übernahme von Monrol im Rahmen seines Plans zur erheblichen Ausweitung der Lutetium-177-Kapazitäten und der Präsenz im Bereich der Positronen-Emissions-Tomographie (PET) ab

Dies positioniert Curium als führenden Hersteller des Isotops Lu-177Integration innovativer F&E-Expertise und Pipeline für CuriumVerbesserung der geografischen Abdeckung und Lieferkette von Curium...